Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring · 2026-07 · 18 (3)
DOI: 10.1002/dad2.70416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, online erschienen am 08.07.2026. Verfasst von Jonas Alexander Jarholm und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology Akershus University Hospital Lørenskog Norway. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Danmarks Grundforskningsfond.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION Peak width of skeletonized mean diffusivity (PSMD) is a candidate magnetic resonance imaging marker for global white matter integrity. We investigated the value of PSMD in predicting clinical progression in amyloid‐positive and amyloid‐negative individuals. METHODS PSMD, cognition, and amyloid status were measured in 254 subjects from the Dementia Disease Initiation (DDI) cohort and 211 subjects from the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Survival analysis was conducted on 166 DDI subjects and validated in 178 ADNI subjects using Clinical Dementia Rating scale. RESULTS High PSMD amyloid‐positive individuals had an increased risk of clinical progression relative to those with low PSMD, driven by independent additive effects of amyloid pathology and PSMD. Higher PSMD was predominantly associated with slower processing speed and reduced executive function, but not with memory performance. DISCUSSION Combining PSMD with amyloid status may improve the prediction of clinical progression in Alzheimer's disease, particularly in relation to executive and processing speed domains.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology Akershus University Hospital Lørenskog Norway.
- Institute of Clinical Medicine University of Oslo Oslo Norway.
- Department of Neurology University Hospital of North Norway Tromsø Norway.
- Department of Psychology Faculty of Health Sciences The Arctic University of Norway Tromsø Norway.
- Department of Computer Science Pioneer Centre for Artificial Intelligence University of Copenhagen Copenhagen Denmark.
- Clinical Molecular Biology (EpiGen) Medical Division Akershus University Hospital and University of Oslo Oslo Norway.
ORCID-Profile: Sandra Tecelão
Förderung
- Danmarks Grundforskningsfond
Zitieren
APA
Jarholm, J. A., Tecelão, S., Kirsebom, B. E., Ghazi, M. M., Pålhaugen, L., Gísladóttir, B., Gonzalez-Ortiz, F., Akhavi, M. S., Hopp, E., Fjell, A. M., Timón-Reina, S., Nielsen, M., Blennow, K., Aarsland, D., Bjørnerud, A., Selnes, P., & Fladby, T. (2026). Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 18(3). https://doi.org/10.1002/dad2.70416
Vancouver
Jarholm JA, Tecelão S, Kirsebom BE, Ghazi MM, Pålhaugen L, Gísladóttir B, et al. Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. 2026;18(3). doi:10.1002/dad2.70416
BibTeX
@article{Jarholm2026,
author = {Jarholm, Jonas Alexander and Tecelão, Sandra and Kirsebom, Bjørn-Eivind and Ghazi, Mostafa Mehdipour and Pålhaugen, Lene and Gísladóttir, Berglind and Gonzalez-Ortiz, Fernando and Akhavi, Mehdi Sadat and Hopp, Einar and Fjell, Anders Martin and Timón-Reina, Santiago and Nielsen, Mads and Blennow, Kaj and Aarsland, Dag and Bjørnerud, Atle and Selnes, Per and Fladby, Tormod},
title = {Independent prognostic value of peak width of skeletonized mean diffusivity on clinical progression in Alzheimer's disease},
journal = {Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring},
year = {2026},
volume = {18},
number = {3},
doi = {10.1002/dad2.70416}
}
EUVIMED